Compare SLE & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SLE | PRPO |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 177.4M | 42.0M |
| IPO Year | 2019 | 2000 |
| Metric | SLE | PRPO |
|---|---|---|
| Price | $3.56 | $26.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $60.00 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 131.5K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 92.15 |
| EPS | N/A | ★ N/A |
| Revenue | $2,064,000.00 | ★ $24,049,000.00 |
| Revenue This Year | $24.86 | N/A |
| Revenue Next Year | $49.77 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 90.41 | 29.77 |
| 52 Week Low | $0.48 | $16.01 |
| 52 Week High | $11.43 | $33.63 |
| Indicator | SLE | PRPO |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 51.57 |
| Support Level | $2.89 | $25.95 |
| Resistance Level | $4.89 | $29.20 |
| Average True Range (ATR) | 0.75 | 2.27 |
| MACD | -0.06 | -0.18 |
| Stochastic Oscillator | 17.10 | 40.06 |
Super League Enterprise Inc connects brands with the gaming population of around 3.5 billion through advertising and branded content programs across gaming and digital media platforms. The Company generates revenue by delivering these programs through proprietary interactive formats, creator content, immersive experiences, data-driven insights, and strategic campaign services designed to improve marketing performance. By translating player behavior into actionable intelligence, Super League serves as a trusted partner helping brands reach and influence consumers who play video games. With a deep understanding of this engaged yet under-monetized audience, it is positioned to capture an increasing share of brand advertising spend as the market evolves.
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.